The effect of metformin combined with liraglutide on gut microbiota of Chinese patients with type 2 diabetes

被引：0
|
作者：
Xiaohong Niu
Panpan Lu
Linqing Huang
Yan Sun
Miaomiao Jin
Jing Liu
Xing Li
机构：
[1] Changzhi Medical College Affiliated Heji Hospital,Department of Endocrinology
[2] Changzhi Medical College,Department of Endocrinology
[3] Second Hospital of Shanxi Medical University,Department of Endocrinology
来源：
International Microbiology | 2024年 / 27卷
关键词：
Glucagon-like peptide-1 agonist; Gut microbiota; Liraglutide; Metformin; Type-2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 276
页数：11
相关论文
共 50 条
  • [11] Gut microbiota's role in the enhancement of type 2 diabetes treatment by a traditional Chinese herbal formula compared to metformin
    Xia, Chengdong
    Yue, Liya
    Wang, Yinyu
    Li, Cuidan
    Ma, Guannan
    Ju, Yingjiao
    Wang, Peihan
    Wang, Jie
    Jiang, Xiaoyuan
    Wang, Xiaotong
    Chen, Fei
    MICROBIOLOGY SPECTRUM, 2025,
  • [12] Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
    Ying, Xing
    Zheng, Rongjiong
    Kahaer, Mayila
    Jiang, Chunhui
    Wulasihan, Muhuyati
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [13] Effect of liraglutide combined with metformin or acarbose on glucose control in type 2 diabetes mellitus and risk factors of gastrointestinal adverse reactions
    Ren, Gaofei
    Ma, Xiaojun
    Jiao, Pengfei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (05): : 3207 - 3215
  • [14] Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with Type 2 diabetes mellitus
    Keskin, L.
    Yaprak, B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (18) : 6813 - 6820
  • [15] Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment
    Jonnalagadda, Venu Gopal
    Kumar, Uppulapu Shravan
    Afsar, Shaik
    MBIO, 2018, 9 (04):
  • [16] Gut microbiota compositions and metabolic functions in type 2 diabetes differ with glycemic durability to metformin monotherapy
    Hung, Wei-Wen
    Peng, Po
    Tsai, Yi-Chun
    Jhou, Pei-Syuan
    Chang, Chen-Chia
    Hsieh, Ching-Chun
    Su, Yong-Chao
    Dai, Chia-Yen
    Hung, Wei-Chun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
  • [17] Metformin-induced changes of the gut microbiota in patients with type 2 diabetes mellitus: results from a prospective cohort study
    Gao, Yuting
    Zhao, Tianyi
    Lv, Na
    Liu, Shixuan
    Yuan, Tao
    Fu, Yong
    Zhao, Weigang
    Zhu, Baoli
    ENDOCRINE, 2024, 85 (03) : 1178 - 1192
  • [18] Gut microbiota of patients with type 2 diabetes and gastrointestinal intolerance to metformin differs in composition and functionality from tolerant patients
    Diaz-Perdigones, Cristina Ma
    Munoz-Garach, Araceli
    Dolores Alvarez-Bermudez, Maria
    Moreno-Indias, Isabel
    Tinahones, Francisco J.
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 145
  • [19] Efficacy and safety of liraglutide monotherapy compared With metformin in Japanese overweight/obese patients with type 2 diabetes
    Tanaka, Kumiko
    Saisho, Yoshifumi
    Kawai, Toshihide
    Tanaka, Masami
    Meguro, Shu
    Irie, Junichiro
    Imai, Takatoshi
    Shigihara, Toshikatsu
    Morimoto, Jiro
    Yajima, Ken
    Atsumi, Yoshihito
    Takei, Izumi
    Itoh, Hiroshi
    ENDOCRINE JOURNAL, 2015, 62 (05) : 399 - 409
  • [20] Gut Microbiota and Subclinical Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Tsai, Hui-Ju
    Tsai, Wei-Chung
    Hung, Wei-Chun
    Hung, Wei-Wen
    Chang, Chen-Chia
    Dai, Chia-Yen
    Tsai, Yi-Chun
    NUTRIENTS, 2021, 13 (08)
12345